Stenocare AS (OCSE:STENO) Common Stock: kr3.47 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OCSE:STENO Stenocare AS OCSE:STENO
43 GF Score
Price kr1.01
GF Value kr2.31
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Stenocare AS Common Stock?

Stenocare AS OCSE:STENO +3.06% 43 Common Stock is kr3.47 Mil as of Mar. 2026. GuruFocus rates OCSE:STENO with a GF Score™ of 43/100 and a GF Value™ of kr2.31 (Possible Value Trap). The stock has 4 warning signs investors should review.

Stenocare AS's quarterly common stock increased from Sep. 2025 (kr3.07 Mil) to Dec. 2025 (kr3.47 Mil) but then stayed the same from Dec. 2025 (kr3.47 Mil) to Mar. 2026 (kr3.47 Mil).

Stenocare AS's annual common stock increased from Dec. 2023 (kr1.47 Mil) to Dec. 2024 (kr1.62 Mil) and increased from Dec. 2024 (kr1.62 Mil) to Dec. 2025 (kr3.47 Mil).

Stenocare AS Common Stock Historical Data

* Premium members only.

The historical data trend for Stenocare AS's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Stenocare AS Common Stock Chart

Stenocare AS Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Common Stock
Get a 7-Day Free Trial 0.93 0.93 1.47 1.62 3.47

Stenocare AS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.07 3.07 3.07 3.47 3.47
OCSE:STENO
43GF Score
Stenocare AS OCSE:STENO
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Stenocare AS Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of kr3.47 Mil mean?
Stenocare AS (OCSE:STENO) has a Common Stock of kr3.47 Mil as of Mar. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Stenocare AS and its competitors.
Is Stenocare AS's Common Stock too high?
Stenocare AS's current Common Stock is kr3.47 Mil. Overall, Stenocare AS has a GF Score™ of 43/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Stenocare AS's Common Stock compare to ZTS and UTHR?
Stenocare AS's Common Stock of kr3.47 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Drug Manufacturers company?
A good Common Stock depends on the Drug Manufacturers industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Stenocare AS and its competitors. Stenocare AS's current Common Stock is kr3.47 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Stenocare AS stock overvalued right now?
Based on GuruFocus' analysis, Stenocare AS (OCSE:STENO) is currently considered Possible Value Trap. The stock's GF Value™ is kr2.31, compared to a current price of kr1.01 — trading 56.3% below its estimated fair value. The current Common Stock is kr3.47 Mil. Stenocare AS's overall GF Score™ is 43/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Stenocare AS (OCSE:STENO), the current Common Stock is kr3.47 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Stenocare AS (OCSE:STENO) Overvalued in 2026?

Based on GuruFocus' analysis, Stenocare AS stock appears to be undervalued. The current stock price of kr1.01 is trading 56.3% below its estimated GF Value™ of kr2.31. GuruFocus considers Stenocare AS to be Possible Value Trap.

Key valuation signals for OCSE:STENO:

  • Common Stock: kr3.47 Mil
  • GF Value™: kr2.31 vs. price of kr1.01 (56.3% below fair value)
  • GF Score™: 43/100 with 4 warning signs

No single metric tells the full story. See the OCSE:STENO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Stenocare AS Business Description

Other Exchanges S7C:Germany
Address Lejrvej 9, Vaerlose, DNK, 93500
Stenocare AS is a Danish company engaged in the cultivation and production of medical cannabis products through pharmacies and hospitals. The company's business operations include the distribution and sales of imported products to several markets which also includes local cultivation and production of its medical cannabis products. Stenocare is well positioned to become a market leader in Denmark and a vendor in Europe. The company is a supplier of medical cannabis oil for patients in Denmerk, Sweden, UK, Australia and Norway.
43GF Score

Get the complete analysis for OCSE:STENO

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr1.01
Price
kr2.31
GF Value